Literature DB >> 16125485

Relation of T-axis abnormalities to coronary artery disease and survival after cardiac catheterization.

Kannayiram Alagiakrishnan1, Jeffrey D Beitel, Michelle M Graham, Danielle Southern, Merril Knudtson, William A Ghali, Ross T Tsuyuki.   

Abstract

We investigated the association of an abnormal T axis with angiographic indicators of coronary artery disease and mortality. In univariate analysis, no significant association was observed between an abnormal T axis and extent of coronary artery disease (p = 0.928). An abnormal T axis was a significant predictor of overall mortality (p = 0.035) for death at any time in our unadjusted survival analysis, and a trend toward poorer survival persisted after adjustment for clinical covariates.

Entities:  

Mesh:

Year:  2005        PMID: 16125485     DOI: 10.1016/j.amjcard.2005.04.034

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

1.  Cystatin C estimated renal dysfunction predicts T wave axis deviation in US adults: results from NHANES III.

Authors:  Mohammed F Faramawi; James L Caffrey; Jamshid Amanzadeh; Lakpa Diku Sharpa; Raquel Qualls-Hampton
Journal:  Eur J Epidemiol       Date:  2010-12-24       Impact factor: 8.082

2.  Abnormal T-wave axis is associated with coronary artery calcification in older adults.

Authors:  Matthew L Scherer; Thor Aspelund; Sigurdur Sigurdsson; Robert Detrano; Melissa Garcia; Gary F Mitchell; Lenore J Launer; Gudmundur Thorgeirsson; Vilmundur Gudnason; Tamara B Harris
Journal:  Scand Cardiovasc J       Date:  2009-08       Impact factor: 1.589

3.  An administrative data merging solution for dealing with missing data in a clinical registry: adaptation from ICD-9 to ICD-10.

Authors:  Danielle A Southern; Colleen M Norris; Hude Quan; Fiona M Shrive; P Diane Galbraith; Karin Humphries; Min Gao; Merril L Knudtson; William A Ghali
Journal:  BMC Med Res Methodol       Date:  2008-01-23       Impact factor: 4.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.